https://www.medscape.com/viewarticle/985847
0
0
12/19/22 at 11:02pm
Organization
Medscape
31 words
0
Comments
The expanded indication for pafolacianine (Cytalux) follows an initial approval in November 2021 for use in patients with ovarian cancer.
You are the first to view
Create an account
or login to join the discussion